BATH & BODY WORKS, INC. (BBWI): what the price assumes

boothcheck covers BATH & BODY WORKS, INC. (BBWI) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-25.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/BBWI

Headline

FieldValue
TickerBBWI
CompanyBATH & BODY WORKS, INC.
Sector / IndustryConsumer Cyclical
Current price$19.31/sh
CompositionStores - U.S. and Canada 77% / Direct - U.S. and Canada 19% / International 4%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)9.1%
Operating margin today16.7%
Margin compression (value-band)-7.6pp
Multiple paid7x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 8% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history-0.38σ
cohort percentile (of 212 peers)5

Valuation X-Ray

The price is supported by earnings-power and relative-multiple value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0
Earnings0.36x2justifies
Relative0.30x2justifies
Growth1.47x2expensive

Families that justify the price: Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 4.6%); the inversion above states its own rate.

Per-Model Detail (n=6)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$113.550.17xnoFCF base $1.0B, growth -2% (input: historical growth), terminal g 0.5%, WACC 4.6%, 5yr projection
DCF Exit MultipleGrowth$45.030.43xnoExit EV/EBITDA: 4.0x / 5.6x / 7.6x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$54.490.35xyesP/E 14x (blended: static sector reference 20x + trailing (TTM) 5x), scenarios: 11.8x / 14.0x / 16.2x (bear / base = reference held flat / bull), EV/EBITDA 10.63x
Simple DDMGrowth$8.582.25xyesDPS $0.79, g=0.0% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$28.140.69xyesStage 1: 20% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAssetno
Two-Stage Excess ReturnAssetno
Discounted Future Market CapGrowth$13.861.39xnoRev $7.2B, growth -2% (input: historical growth; tapered), Terminal P/S: 0.5x / 0.5x / 0.6x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$133.000.15xnoEPS $3.80, growth 35% (input: historical EPS growth), PEG=0.14 (Undervalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$103.320.19xnoNormalized EBIT (5y avg op income, one-time charges added back) $1.36B × (1−28%) / WACC 4.6% → EPV (no growth)
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelative$80.060.24xyesEBITDA $1.45B × sector EV/EBITDA 14.0x
FCF YieldEarnings$34.460.56xyesFCF $1031.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$122.610.16xyesEPS $3.80 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelative$53.630.36xnoRevenue $7.21B × sector P/S 1.5x
PEG Fair ValueRelative$142.500.14xnoEPS $3.80 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$41.080.47xnoEPS $3.80 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Bath & Body Works (consolidated)operatingenterprise7.3B reported-currencywithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$3.1b
Net debt / NOPAT (after-tax)3.56x
Net debt / operating income (pre-tax)2.56x
Interest coverage4.5x
Share count CAGR (buyback)-3.3%
Burning cashno

Bullet Takeaways

Bull Case

Read this company as what it is. Bath & Body Works is mature, and mature is not a criticism; it is an instruction about which numbers matter. Nobody buys a business like this for the revenue line. They buy it for what a fixed base of customers, buying a repeatable and cheap product at a high margin, throws off in cash, and for what management does with that cash. On those two questions the record is considerably better than the share price suggests.

Start with the margin, because it is the part that is genuinely hard to replicate. On trailing figures the company earns an operating margin of about 12.8%. Among its listed comparables that is at the top of the range: ULTA runs 12.4% on far larger revenue, VSCO manages 4.8%, SIG 5.6% and BBY 3.7%, and only WSM, at 18.0%, sits above it. A soap and candle retailer out-earning most of specialty retail per dollar of sales is not an accident of a good year. It is a vertically managed product line, mostly own-brand, mostly designed and merchandised in-house, sold at a price the customer treats as small.

The cash conversion is the point. Management expects roughly 600 million dollars of free cash flow in fiscal 2026, against a market value of about 4.0 billion dollars. Whatever one thinks of the growth outlook, a business handing back that proportion of its own market value in annual cash is being priced as though the cash will stop.

It has not been hoarded. The share count has fallen at roughly 4.5% a year since April 2022, retiring about a sixth of the company over four years, and the buyback runs alongside a dividend, disclosed for fiscal 2024 as $0.80 per share, or $177 million. Repurchases at a single-digit multiple of earnings do more per dollar than repurchases at twenty times, which is the mechanical reason a cheap, cash-generative business shrinking its own share count can compound per-share value while total profit goes sideways.

Management is not pretending the last two years went well. The 10-K frames the turnaround under a named operating plan and lists what it believes survives it: we believe the following competitive advantages endure and will help enable our return to sustainable growth: • We are a market leader in attractive, growing categories; • We are an iconic brand. Whether the plan works is open. What is not open is the starting position: a national store fleet, a brand customers walk in for by name, and an entirely fixed-rate borrowing stack, with the company confirming that All of our debt as of January 31, 2026 has fixed rates.

The bear case on erosion is fair and unresolved. What the bull case says is that the price has stopped asking the question. It no longer requires growth, a turnaround, or even stability. It requires only that the decline be slower than steep.

Bear Case

The advantage here was always the trip. A customer walked past the shop, smelled it, went in for one thing and left with four, and did it several times a year. That habit is what justified the store fleet, the seasonal assortment resets and the margin. The data now shows the habit thinning. The company describes net sales falling due to a decline in transactions mostly offset by increased order size, which is the specific shape of erosion that matters: fewer visits, papered over by getting more from each one. Basket size can be engineered. Footfall cannot.

Competition is pressing exactly where that habit lives. The 10-K names the mechanism without softening it, warning that Increased competition, combined with declines in store and/or direct channel traffic, could result in price reductions, increased marketing expenditures and loss of pricing power and market share. Body care and home fragrance have low barriers on the product side; what protected this company was distribution and brand familiarity, and both are cheaper to attack now than they were when the store fleet was built. Meanwhile the comparable that is growing, ULTA, put up 11.3% revenue growth against a group where most names are flat.

The profit line has already turned. The company reports that For 2025, Operating Income was $1,126 million, which decreased $140 million, or 11% against the prior year, and it has guided full-year 2026 net sales to fall between 2.5% and 4.5%. A retailer with a heavy fixed cost base loses profit faster than it loses sales, because rent and store labour do not shrink with traffic. Two consecutive years of declining sales in a fleet of leased boxes is how operating deleverage begins rather than how it ends.

The seasonality concentrates the risk into a few weeks. The annual report states that the fourth quarter typically accounts for approximately 40% of our Net Sales and is our most profitable quarter. Nearly half the year's revenue, and a larger share of the year's profit, is decided between late November and Christmas. A single soft holiday does not just dent a quarter; it resets the base that the following year's comparisons and the following year's inventory buy are built on.

The balance sheet removes the margin for error. Net borrowings run about $3.1B measured as funded debt against cash, and closer to 4.1 billion dollars once lease obligations are counted, which is the right way to look at a company whose operating footprint is entirely rented. That is real leverage against a profit stream that is declining rather than growing, and it is why the equity is a smaller and more volatile slice of the enterprise than the market value alone implies.

None of which makes this expensive. The methods that value earnings and compare multiples both land above the price, so the bear case is not that the shares cost too much. It is that a business shrinking at the top line with fixed rent, fixed debt and a holiday-dependent profit season can keep looking cheap all the way down, and that the cash flow funding the buyback is generated by the same store fleet whose traffic is falling.

Valuation

Something in this picture has to give. The price puts the whole enterprise at about 11 times company-wide operating profit. That is low enough to sit under what a business shrinking its operating profit by five percent every single year would still be worth. Read it as a boundary rather than a forecast: the market is not pricing a particular rate of shrinkage, it is pricing something worse than steady erosion, and no single path sits comfortably behind it.

The methods split along the line you would expect. Approaches that value earnings power, capitalising the cash the business actually throws off, land above the price. Approaches built on comparable multiples land well above it. The dividend-based approaches, which value only what is paid out and treat the growth rate as roughly nothing, land below the price, and they are the only group that reads the shares as rich. A retailer that returns most of its cash through repurchase rather than dividend will always look poor through a dividend lens; that is a feature of the lens, not a finding about the company.

Against its sector, the multiple sits in the lower half of the peer range. The peer set explains why that is odd. ULTA earns a 12.4% operating margin and grew 11.3%; WSM earns 18.0% on essentially flat revenue; SIG earns 5.6%, VSCO 4.8% and BBY 3.7%. Bath & Body Works earns about 12.8% on trailing figures, which puts it in the top group on profitability while being priced with the bottom group. The market is applying a discount for the direction of travel rather than for the level of returns.

The filed inputs supporting all of this are ordinary. Revenue divides 77% through stores in the United States and Canada, 19% through direct and 4% internationally, and the fourth quarter typically accounts for approximately 40% of our Net Sales and is our most profitable quarter. The most recent full year produced operating income the company reports as For 2025, Operating Income was $1,126 million, which decreased $140 million, or 11% against the year before, and management expects roughly 600 million dollars of free cash flow in fiscal 2026.

Solvency is where the cheapness earns its discount. Net borrowings of $3.1B on a funded-debt basis, rising toward 4.1 billion dollars once leases are included, sit against a profit stream that has fallen for two consecutive years. The debt itself is not the near-term problem, since the company states that All of our debt as of January 31, 2026 has fixed rates and it has been redeeming notes rather than adding them. The problem is arithmetic: leverage magnifies whatever the operating line does next, and the operating line is currently going down. That is the trade on offer at this price, stated plainly.

Catalysts

Guidance for the current year points down. Management expects full-year 2026 net sales to decline between 2.5% and 4.5% against 2025, alongside roughly 600 million dollars of free cash flow. The first quarter, reported on May 27, 2026, came in ahead of the company's own guidance with net sales of about 1.4 billion dollars, down 3%. Beating a lowered bar is worth something, and it is not the same as the decline stopping.

There is also a change in the finance seat. The company disclosed that its chief financial officer would be leaving alongside those first-quarter results. A departure announced in the middle of a turnaround is not by itself a verdict on the turnaround, but it does mean the next set of guidance revisions will be delivered by someone with no ownership of the last set.

Guidance behaviour at this company has historically leaned optimistic. Since 2006 management has raised its outlook on 49 separate occasions, reaffirmed it on 8, cut it once and withdrawn it once. That record was built across a long stretch when the brand was expanding, which makes the current sequence of downward revisions a genuine break in pattern rather than routine conservatism. The fourth quarter is the one that settles it, since it carries roughly 40% of the year's sales and the larger part of its profit.

Peer Cohorts (Per Segment, With Filing Citations)

Bath & Body Works (consolidated) (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Bath & Body Works first quarter fiscal 2026 results, May 27, 2026 · same release

View the full interactive BBWI report on boothcheck